高雄醫學大學圖書館 |

Complete accounts of integrated drug discovery and development.recent examples from the pharmaceutical industry /. Volume 1 :

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Complete accounts of integrated drug discovery and development./ Ahmed F. Abdel-Magid, editor, Therachem Research Medilab, LLC, Chelsea, Alabama, United States, Jaan A. Pesti, editor, EnginZyme AB, Stockholm, Sweden, Rajappa Vaidyanathan, editor, Bristol-Myers Squibb, Bangalore, India ; sponsored by the ACS Division of Organic Chemistry.
其他題名:	recent examples from the pharmaceutical industry /
其他作者:	Vaidyanathan, Rajappa,
面頁冊數:	1 online resource (314 pages) :illustrations (some color). :
附註:	Distributed in print by Oxford University Press.
標題:	MEDICAL / Research. -
電子資源:	https://pubs.acs.org/doi/book/10.1021/bk-2018-1307
ISBN:	9780841233966

Complete accounts of integrated drug discovery and development.recent examples from the pharmaceutical industry /. Volume 1 :
Complete accounts of integrated drug discovery and development.recent examples from the pharmaceutical industry /Volume 1 :Ahmed F. Abdel-Magid, editor, Therachem Research Medilab, LLC, Chelsea, Alabama, United States, Jaan A. Pesti, editor, EnginZyme AB, Stockholm, Sweden, Rajappa Vaidyanathan, editor, Bristol-Myers Squibb, Bangalore, India ; sponsored by the ACS Division of Organic Chemistry. - 1 online resource (314 pages) :illustrations (some color). - ACS symposium series,13071947-5918 ;. - ACS symposium series ;1014..

Distributed in print by Oxford University Press.

Includes bibliographical references and index.

Discovery and Development of GDC-0994: A Selective and Efficacious Small Molecule Inhibitor of ERK1/2 /Linghu, Xin, Ideaya Biosciences, 7000 Shoreline Ct Suite 350, South San Francisco, California 94080-4990, United States; Wong, Nicholas, Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States; Blake, James F., Array BioPharma Inc, 3200 Walnut Street, Boulder, Colorado 80301, United States; Gaudino, John J., Array BioPharma Inc, 3200 Walnut Street, Boulder, Colorado 80301, United States; Moffat, John G., Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States /http://dx.doi.org/10.1021/bk-2018-1307.ch001 --

ISBN: 9780841233966

Standard No.: bk-2018-1307Subjects--Topical Terms:

469015
MEDICAL / Research.

LC Class. No.: RM301.25 / .C66 2018 v.1

Dewey Class. No.: 615.1/9

National Library of Medicine Call No.: QV 745 / C736 2018

Complete accounts of integrated drug discovery and development.recent examples from the pharmaceutical industry /. Volume 1 :
LDR:06480nam a2200325 i 4500 001 339745
006 m o d
007 cr*cn ---unuuu
008 210625s2018 dcua ob 101 0 eng d
020 $a 9780841233966 $q electronic
024 8 $a bk-2018-1307
035 $a ccn00862473
040 $a NjRocCCS $b eng $e rda $c NjRocCCS
050 4 $a RM301.25 $b .C66 2018 v.1
060 4 $a QV 745 $b C736 2018
082 0 4 $a 615.1/9 $2 23
084 $a MED071000 $a MED106000 $2 bisacsh
245 0 0 $a Complete accounts of integrated drug discovery and development. $p Volume 1 : $b recent examples from the pharmaceutical industry / $c Ahmed F. Abdel-Magid, editor, Therachem Research Medilab, LLC, Chelsea, Alabama, United States, Jaan A. Pesti, editor, EnginZyme AB, Stockholm, Sweden, Rajappa Vaidyanathan, editor, Bristol-Myers Squibb, Bangalore, India ; sponsored by the ACS Division of Organic Chemistry.
264 1 $a Washington, DC : $b American Chemical Society, $c 2018.
300 $a 1 online resource (314 pages) : $b illustrations (some color).
336 $a text $2 rdacontent
337 $a computer $2 rdamedia
338 $a online resource $2 rdacarrier
490 1 $a ACS symposium series, $x 1947-5918 ; $v 1307
500 $a Distributed in print by Oxford University Press.
504 $a Includes bibliographical references and index.
505 0 0 $t Discovery and Development of GDC-0994: A Selective and Efficacious Small Molecule Inhibitor of ERK1/2 / $r Linghu, Xin, Ideaya Biosciences, 7000 Shoreline Ct Suite 350, South San Francisco, California 94080-4990, United States; Wong, Nicholas, Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States; Blake, James F., Array BioPharma Inc, 3200 Walnut Street, Boulder, Colorado 80301, United States; Gaudino, John J., Array BioPharma Inc, 3200 Walnut Street, Boulder, Colorado 80301, United States; Moffat, John G., Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States / $u http://dx.doi.org/10.1021/bk-2018-1307.ch001 -- $t Preclinical Identification and Development of AM-6138: An Inhibitor of BACE1 for the Treatment of Alzheimer’s Disease / $r Mennen, Steven M., Process Development, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States; Stellwagen, John, Department of Medicinal Chemistry, Amgen Discovery Research, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States; White, Ryan D., Department of Medicinal Chemistry, Amgen Discovery Research, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States / $u http://dx.doi.org/10.1021/bk-2018-1307.ch002 -- $t Discovery and Chemical Development of Verubecestat, a BACE1 Inhibitor for the Treatment of Alzheimer’s Disease / $r Thaisrivongs, David A., Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States; Morris, William J., Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States; Scott, Jack D., Discovery Chemistry, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States / $u http://dx.doi.org/10.1021/bk-2018-1307.ch003 -- $t Discovery and Chemical Development of JNJ-50138803, a Clinical Candidate BACE1 Inhibitor / $r Gijsen, Harrie J. M., Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium; Lin, Jinguang, STA Pharmaceuticals, A WuxiApptec Company, 589 N. Yulong Rd., Changzhou, 213127, China; Houpis, Yannis, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium / $u http://dx.doi.org/10.1021/bk-2018-1307.ch004 -- $t Discovery and Development of Ruzasvir: An Investigational Next Generation Pan-Genotype HCV Nonstructural Protein 5A (NS5A) Inhibitor for the Cure of Hepatitis C Virus Infections / $r Tong, Ling, Discovery Chemistry, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States; Kozlowski, Joseph A., Discovery Chemistry, MRL, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States; Campeau, Louis-Charles, Process Research & Development, MRL, Merck & Co., Inc., 126 East Lincoln Ave., P.O. Box 2000, Rahway, New Jersey 07065, United States; Yin, Jingjun, Process Research & Development, MRL, Merck & Co., Inc., 126 East Lincoln Ave., P.O. Box 2000, Rahway, New Jersey 07065, United States / $u http://dx.doi.org/10.1021/bk-2018-1307.ch005 -- $t AZD6564, Discovery of a Potent 5-Substituted Isoxazol-3-ol Fibrinolysis Inhibitor and Development of an Enantioselective Large-Scale Route for Its Preparation / $r Karlsson, Staffan, Early Chemical Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, SE-431 83 Gothenburg, Sweden; Pettersen, Daniel, Medicinal Chemistry, Cardiovascular, Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, SE-431-83 Gothenburg, Sweden; Sörensen, Henrik, Medicinal Chemistry, Cardiovascular, Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, SE-431-83 Gothenburg, Sweden / $u http://dx.doi.org/10.1021/bk-2018-1307.ch006 -- $t Design and Development of the Glucokinase Activator AZD1656 / $r McKerrecher, Darren, Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca, Darwin Building, Unit 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, United Kingdom; Steven, Alan, Pharmaceutical Technology & Development, AstraZeneca, Charter Way, Macclesfield, SK10 2NA, United Kingdom / $u http://dx.doi.org/10.1021/bk-2018-1307.ch007 -- $t Development of a Reversible P2Y12R Antagonist, AZD1283—Discovery Research and Large-Scale Chemistry / $r Zetterberg, Fredrik, Galecto Biotech AB, Sahlgrenska Science Park, Medicinaregatan 8 A, S-413 46 Gothenburg, Sweden; Aurell, Carl-Johan, Carl-Johan Aurell, AstraZeneca R&D Gothenburg, Pharmaceutical Sciences, Early Chemical Development, Large Scale Chemistry, SE-43183 Mölndal, Sweden / $u http://dx.doi.org/10.1021/bk-2018-1307.ch008 -- $t Discovery, Process Development, and Scale-Up of a Benzoxazepine-Containing mTor Inhibitor / $r Leahy, James W.; Naganathan, Sriram; Andersen, Denise L.; Andersen, Neil G.; Lau, Stephen / $u http://dx.doi.org/10.1021/bk-2018-1307.ch009 -- $t Editors’ Biographies / $u http://dx.doi.org/10.1021/bk-2018-1307.ot001
588 $a Description based on publisher-supplied information and home-page.
590 $a American Chemical Society, ACS Symposium Series eBooks - 2018 Front Files.
650 7 $a MEDICAL / Research. $2 bisacsh $3 469015
650 7 $a MEDICAL / Pharmacology. $2 bisacsh $3 450489
650 1 2 $a TOR Serine-Threonine Kinases $x antagonists & inhibitors. $3 469014
650 1 2 $a Oxazepines. $3 469013
650 1 2 $a Glucokinase. $3 469012
650 1 2 $a Fibrinolysis. $3 469011
650 1 2 $a Hepacivirus. $3 469010
650 1 2 $a Alzheimer Disease $x drug therapy. $3 469009
650 1 2 $a Amyloid Precursor Protein Secretases $x antagonists & inhibitors. $3 469008
650 1 2 $a Extracellular Signal-Regulated MAP Kinases $x antagonists & inhibitors. $3 469007
650 1 2 $a Drug Development. $3 464503
650 1 2 $a Drug Discovery. $3 301877
650 0 $a Rapamycin $x Chemical inhibitors $x Development. $3 469006
650 0 $a Purines $x Receptors $x Antagonists $x Development. $3 469005
650 0 $a G proteins $x Antagonists $x Development. $3 469004
650 0 $a Glucokinase $x Regulation $x Development. $3 469003
650 0 $a Fibrinolysis $x Chemical inhibitors $x Development. $3 469002
650 0 $a Hepatitis C virus $x Treatment $x Technological innovations. $3 469001
650 0 $a Membrane proteins $x Chemical inhibitors $x Development. $3 469000
650 0 $a Alzheimer's disease $x Treatment $x Technological innovations. $3 468999
650 0 $a Protein kinases $x Chemical inhibitors $x Development. $3 468998
650 0 $2 96060 $a Pharmaceutical technology. $3 254322
650 0 $2 96060 $a Pharmaceutical industry. $3 253879
650 0 $2 96060 $a Drug development. $3 232902
700 1 $a Vaidyanathan, Rajappa, $e editor. $u Bristol-Myers Squibb, Bangalore, India. $3 468996
700 1 $a Pesti, Jaan A., $d 1954- $e editor. $u EnginZyme AB, Stockholm, Sweden. $3 468995
700 1 $a Abdel-Magid, Ahmed F., $d 1947- $e editor. $u Therachem Research Medilab, LLC, Chelsea, Alabama, United States. $3 468994
710 2 $a American Chemical Society. $b Division of Organic Chemistry, $e sponsoring body. $3 468997
776 1 $c Original $z 9780841233980 (alk. paper)
830 0 $a ACS symposium series ; $v 1014. $3 311094
856 4 $3 ACS $u https://pubs.acs.org/doi/book/10.1021/bk-2018-1307